International Journal of Radiation Oncology * Biology * Physics
Volume 72, Issue 2 , Pages 327-334 , 1 October 2008

Report From the International Atomic Energy Agency (IAEA) Consultants' Meeting on Elective Nodal Irradiation in Lung Cancer: Small-Cell Lung Cancer (SCLC)

  • Gregory M.M. Videtic, M.D., C.M., F.R.C.P.C.

      Affiliations

    • Department of Radiation Oncology, The Cleveland Clinic, Cleveland, OH
    • Corresponding Author InformationReprint requests to: Gregory M. M. Videtic, MD, Department of Radiation Oncology/T28, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195. Tel: (216) 444-9797; Fax: (216) 445-1068
    • ,
  • José S.A. Belderbos, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, The Netherlands Cancer Institute-Antoni van Leewenhoek Hospital, Amsterdam, The Netherlands
    • ,
  • Feng-Ming (Spring) Kong, M.D., Ph.D., M.P.H.

      Affiliations

    • Department of Radiation Oncology, University of Michigan, Ann Arbor, MI
    • ,
  • Lucyna Kepka, M.D.

      Affiliations

    • Department of Radiation Oncology, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland
    • ,
  • Mary K. Martel, Ph.D.

      Affiliations

    • Professor Department of Radiation Physics, Division of Radiation Oncology, UT MD Anderson Cancer Center, Houston, TX
    • ,
  • Branislav Jeremic, M.D., Ph.D.

      Affiliations

    • International Atomic Energy Agency, Vienna, Austria

Received 4 March 2008 ,Revised 25 March 2008 ,Accepted 26 March 2008.

References 

  1. Emami B. Three-dimensional conformal radiation therapy in bronchogenic carcinoma. Semin Radiat Oncol. 1996;6:92–97
  2. Senan S, De Ruysscher D. Critical review of PET-CT for radiotherapy planning in lung cancer. Crit Rev Oncol Hematol. 2005;56:345–351
  3. Kong FM, Gaspar LE, Komaki R, et al. Patterns of practice in radiation dose prescription and treatment planning for patients with lung cancer among members of American Society of Therapeutic Radiology and Oncology. Int J Radiat Oncol Biol Phys. 2007;69(Suppl. 1):S483
  4. De Ruysscher D, Bremer RH, Koppe F, et al. Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: A phase II trial. Radiother Oncol. 2006;80:307–312
  5. Cooper S, Spiro SG. Small cell lung cancer: Treatment review. Respirology. 2006;11:241–248
  6. Lee CB, Morris DE, Fried DB, et al. Current and evolving treatment options for limited stage small cell lung cancer. Curr Opin Oncol. 2006;18:162–172
  7. Samson DJ, Seidenfeld J, Simon GR, et al. American College of Chest Physicians. Evidence for management of small cell lung cancer: ACCP evidence-based clinical practice guidelines 2nd ed. Chest. 2007;132(3 Suppl.):314S–323S
  8. Fried DB, Morris DE, Poole C, et al. Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer. J Clin Oncol. 2004;22:4785–4793
  9. Huncharek M, McGarry R. A meta-analysis of the timing of chest irradiation in the combined modality treatment of limited-stage small cell lung cancer. Oncologist. 2004;9:6665–6672
  10. Pijls-Johannesma M, De Ruysscher D, Vansteenkiste J, et al. Timing of chest radiotherapy in patients with limited stage small cell lung cancer: A systematic review and meta-analysis of randomised controlled trials. Cancer Treat Rev. 2007;33:461–473
  11. Spiro SG, James LE, Rudd RM, et al. London Lung Cancer Group. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: A London Lung Cancer Group multicenter randomized clinical trial and meta-analysis. J Clin Oncol. 2006;24:3823–3830
  12. Jeremic B. Timing of concurrent radiotherapy and chemotherapy in limited-disease small-cell lung cancer: “Meta-analysis of meta-analyses”. Int J Radiat Oncol Biol Phys. 2006;64:981–982
  13. Turrisi AT, Kim K, Blum R, et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med. 1999;340:265–2671
  14. Kies MS, Mira JG, Crowley JJ, et al. Multimodal therapy for limited small-cell lung cancer: A randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide-field versus reduced-field radiation in partial responders: A Southwest Oncology Group Study. J Clin Oncol. 1987;5:592–600
  15. Mira JG, Livingston RB. Evaluation and radiotherapy implications of chest relapse patterns in small cell lung carcinoma treated with radiotherapy-chemotherapy: Study of 34 cases and review of the literature. Cancer. 1980;46:2557–2565
  16. Liengswangwong V, Bonner JA, Shaw EG, et al. Limited-stage small-cell lung cancer: Patterns of intrathoracic recurrence and the implications for thoracic radiotherapy. J Clin Oncol. 1994;12:496–502
  17. Tada T, Minakuchi K, Koda M, et al. Limited-stage small cell lung cancer: Local failure after chemotherapy and radiation therapy. Radiology. 1998;208:511–515
  18. Perez CA, Krauss S, Bartolucci AA, et al. Thoracic and elective brain irradiation with concomitant or delayed multiagent chemotherapy in the treatment of localized small cell carcinoma of the lung: A randomized prospective study by the Southeastern Cancer Study Group. Cancer. 1981;47:2407–2413
  19. White JE, Chen T, McCracken J, et al. The influence of radiation therapy quality control on survival, response and sites of relapse in oat cell carcinoma of the lung: Preliminary report of a Southwest Oncology Group study. Cancer. 1982;50:1084–1090
  20. Arriagada R, Pellae-Cosset B, Ladron de Guevara JC, et al. Alternating radiotherapy and chemotherapy schedules in limited small cell lung cancer: Analysis of local chest recurrences. Radiother Oncol. 1991;20:91–98
  21. Brodin O, Rikner G, Steinholtz L, et al. Local failure in patients treated with radiotherapy and multidrug chemotherapy for small cell lung cancer. Acta Oncol. 1990;29:739–746
  22. Perry MC, Eaton WL, Propert KJ, et al. Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung. N Engl J Med. 1987;316:912–918
  23. Murray N, Coy P, Pater JL, et al. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol. 1993;11:336–344
  24. Work E, Nielsen OS, Bentzen SM, et al. Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer. Aarhus Lung Cancer Group. J Clin Oncol. 1997;15:3030–3037
  25. Jeremic B, Shibamoto Y, Acimovic L, et al. Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: A randomized study. J Clin Oncol. 1997;15:893–900
  26. Skarlos DV, Samantas E, Briassoulis E, et al. Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: A randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG). Ann Oncol. 2001;12:1231–1238
  27. Takada M, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: Results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol. 2002;20:3054–3060
  28. Bogart JA, Herndon JE, Lyss AP, et al. Cancer and Leukemia Group B study 39808. 70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: Analysis of Cancer and Leukemia Group B study 39808. Int J Radiat Oncol Biol Phys. 2004;59:460–468
  29. Baas P, Belderbos JS, Senan S, et al. Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: A Dutch multicenter phase II study. Br J Cancer. 2006;94:625–630
  30. Schild SE, Bonner JA, Hillman S, et al. Results of a phase II study of high-dose thoracic radiation therapy with concurrent cisplatin and etoposide in limited-stage small-cell lung cancer (NCCTG 95-20-53). J Clin Oncol. 2007;25:3124–3129
  31. European Organisation for Research and Treatment of Cancer (EORTC) trial—A randomized controlled trial of concurrent chemo-radiotherapy comparing twice-daily and once-daily radiotherapy schedules in patients with limited stage small cell lung cancer (SCLC) and good performance status. Available at: http://groups.eortc.be/radio/lung.htm Accessed July 9, 2008.
  32. Phase III randomized study of three different thoracic radiotherapy regimens in patients with limited-stage small cell lung cancer receiving cisplatin and etoposide. Available at: http://www.cancer.gov/clinicaltrials/view_clinicaltrials.aspx?version=healthprofessional&cdrid=588879. Accessed July 9, 2008.
  33. Belderbos J, Baas P, Senan S. Reply: Patterns of nodal recurrence after omission of elective nodal irradiation for limited-stage small-cell lung cancer. Br J Cancer. 2007;97:276
  34. van Overhagen H, Brakel K, Heijenbrok MW, et al. Metastases in supraclavicular lymph nodes in lung cancer: Assessment with palpation, US, and CT. Radiology. 2004;232:75–80
  35. van Baardwijk A, Baumert BG, Bosmans G, et al. The current status of FDG-PET in tumour volume definition in radiotherapy treatment planning. Cancer Treat Rev. 2006;32:245–260
  36. Rusch VW. Mediastinoscopy: An endangered species?. J Clin Oncol. 2005;23:8283–8285
  37. Shen YY, Shiau YC, Wang JJ, et al. Whole-body 18F-2-deoxyglucose positron emission tomography in primary staging small cell lung cancer. Anticancer Res. 2002;22:1257–1264
  38. Fischer BM, Mortensen J, Langer SW, et al. A prospective study of PET/CT in initial staging of small-cell lung cancer: Comparison with CT, bone scintigraphy and bone marrow analysis. Ann Oncol. 2007;18:338–345
  39. Schumacher T, Brink I, Mix M, et al. FDG-PET imaging for the staging and follow-up of small cell lung cancer. Eur J Nucl Med. 2001;28:483–488
  40. Hauber HP, Bohuslavizki KH, Lund CH, et al. Positron emission tomography in the staging of small-cell lung cancer: A preliminary study. Chest. 2001;119:950–954
  41. Bradley JD, Dehdashti F, Mintun MA, et al. Positron emission tomography in limited-stage small-cell lung cancer: A prospective study. J Clin Oncol. 2004;22:3248–3254
  42. Kamel EM, Zwahlen D, Wyss MT, et al. Whole-body (18) F-FDG PET improves the management of patients with small cell lung cancer. J Nucl Med. 2003;44:1911–1917
  43. Ulsperger E, Karrer K, Denck H. Multimodality treatment for small cell bronchial carcinoma. Preliminary results of a prospective, multicenter trial. The ISC-Lung Cancer Study Group. Eur J Cardiothorac Surg. 1991;5:306–309
  44. Shepherd FA, Ginsberg RJ, Feld R, et al. Surgical treatment for limited small-cell lung cancer. The University of Toronto Lung Oncology Group experience. J Thorac Cardiovasc Surg. 1991;101:385–393
  45. Sakai M, Ishikawa S, Yamamoto T, et al. Preoperative TNM evaluation of peripheral clinical stage I small cell lung cancer treated by initial lobectomy with adjuvant chemotherapy. Interact Cardiovasc Thorac Surg. 2005;4:118–122
  46. Inoue M, Nakagawa K, Fujiwara K, et al. Results of preoperative mediastinoscopy for small cell lung cancer. Ann Thorac Surg. 2000;70:1620–1623
  47. Inoue M, Miyoshi S, Yasumitsu T, et al. Surgical results for small cell lung cancer based on the new TNM staging system. Thoracic Surgery Study Group of Osaka University, Osaka, Japan. Ann Thorac Surg. 2000;0:1615–1619
  48. Slotman B, Faivre-Finn C, Kramer G, et al. EORTC Radiation Oncology Group and Lung Cancer Group. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med. 2007;357:664–672
  49. Jeremic B, Shibamoto Y, Nikolic N, et al. Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: A randomized study. J Clin Oncol. 1999;17:2092–2099

 Conflict of interest: none.

PII: S0360-3016(08)02470-X

doi: 10.1016/j.ijrobp.2008.03.075

International Journal of Radiation Oncology * Biology * Physics
Volume 72, Issue 2 , Pages 327-334 , 1 October 2008

Article Tools